Back
Regeneron Pharmaceuticals Stock Predictions
10 Best Stocks to Own in 2025
Get your copy now FREE!
Sell
45
REGN
Regeneron Pharmaceuticals
Last Price:
$494.12
Seasonality Move:
7.77%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREERegeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 27% based on the past 34 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 19 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.88%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $605.39. The Score for REGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 27% based on the past 34 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
45
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 19 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.88%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
520.50
Prediction Charts
Market Cap:
65.4B
Price in USD:
605.39
Volume:
756.8K
Beta:
0.95
Technical Analysis
SMA50:
594.46
SMA100:
644.11
SMA200:
799.25
52-Wk Change:
-37.36%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 605.39 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-9 | 549.00 | 527.78 | 552.84 | 527.13 |
| May-12 | 543.82 | 575.63 | 577.99 | 535.29 |
| May-13 | 571.45 | 574.16 | 575.05 | 558.45 |
| May-14 | 576.35 | 571.36 | 580.56 | 567.59 |
| May-15 | 576.13 | 584.99 | 585.26 | 564.91 |
| May-16 | 588.23 | 594.32 | 595.19 | 581.49 |
| May-19 | 588.48 | 596.54 | 598.56 | 586.68 |
| May-20 | 595.01 | 614.79 | 615.45 | 595.01 |
| May-21 | 613.06 | 604.62 | 617.52 | 597.92 |
| May-22 | 603.20 | 596.85 | 605.50 | 592.73 |
| May-23 | 586.85 | 588.34 | 591.64 | 582.37 |
| May-27 | 603.09 | 603.26 | 608.17 | 590.81 |
| May-28 | 603.26 | 591.85 | 606.00 | 590.15 |
| May-29 | 597.06 | 605.39 | 605.73 | 591.02 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.32 per share, a decrease next quarter of $0.30 per share, a decrease this year of $9.42 per share, and an increase next year of $4.86 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.